Abstract
The incidence rate and mortality of non-small cell lung cancer are increasing year by year. Some patients are not sensitive to traditional treatment. Today, with the arrival of the era of immunotherapy, the immunotherapy of non-small cell lung cancer is also progressing and developing. This paper mainly reviews the progress of immunotherapy of non-small cell lung cancer in recent years.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
